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Stem cells are found in all multicellular organisms, including
two broadly deﬁned cell types: embryonic stem cells (ESC)
(C. Y. Cheong and T. Lufkin; and N. Lifantseva et al.)
that are derived from the inner cell mass of blastocyst-
stage embryos and adult stem cells that are present in
a d u l tt i s s u e s( C .M .T e v e ne ta l . ,R .C h u n ge ta l . ,a n d
A. C. Wilber et al.). Nuclear reprogramming refers to the
erasure and remodeling of epigenetic marks, which is a part
of normal mammalian development. This reprogramming
is likely required for totipotency of the newly formed
embryo and erasure of acquired epigenetic changes (Felici).
Advances in stem cells including induced pluripotent stem
(IPS) cells (D. Dey and G. R. D. Evans; and P. Noisa
and R. Parnpai) and nuclear reprogramming (C. M. Teven
et al.) will provide new insights into the mechanisms
of cellular diﬀerentiation, during embryonic development
(N. Lifantsevaa et al.) as well as in adult tissues (C. M.
Teven et al.), and their pluripotency (A. C. Wilber et
al.), which may lead to cell-based therapies (R. Eggen-
schwiler et al.) for several human diseases (R. Chung et
al.).
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